Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 21, 2008; 14(19): 3074-3080
Published online May 21, 2008. doi: 10.3748/wjg.14.3074
Published online May 21, 2008. doi: 10.3748/wjg.14.3074
Figure 2 Comparison of RASSF1A promoter methylation status in tissue and serum samples.
For each patient, the RASSF1A promoter methylation status was analyzed in tumor tissue (T), adjacent normal tissue (N), preoperative serum (S-1), and postoperative serum collected 4 wk after surgery (S-2). Solid boxes indicate methylation, blank ones indicate unmethylation of RASSF1A promoter. GC: Gastric adenocarcinoma; CC: Colorectal adenocarcinoma.
-
Citation: Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, Lu J, Zhu RM, Li GL, Xia XY, Wei XW, Ji HZ, Lu H, Gao Y, Gao WM, Chen LB. Detection of
RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J Gastroenterol 2008; 14(19): 3074-3080 - URL: https://www.wjgnet.com/1007-9327/full/v14/i19/3074.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3074